{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:15:59Z","timestamp":1725635759476},"publisher-location":"Berlin, Heidelberg","reference-count":119,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642787737"},{"type":"electronic","value":"9783642787713"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-3-642-78771-3_27","type":"book-chapter","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T06:07:40Z","timestamp":1321855660000},"page":"349-369","source":"Crossref","is-referenced-by-count":14,"title":["Perspectives of Cytokine Treatment in Malignant Skin Tumors"],"prefix":"10.1007","author":[{"given":"C.","family":"Garbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"[3 Suppl 2]","key":"27_CR1","first-page":"43","volume":"13","author":"DI Abrams","year":"1986","unstructured":"Abrams DI, Volberding PA (1986) Alpha interferon therapy of AIDS-associated Kaposi\u2019s sarcoma. Semin Oncol 13 [3 Suppl 2]:43\u201347","journal-title":"Semin Oncol"},{"key":"27_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-4362.1993.tb01458.x","volume":"32","author":"GF Altomare","year":"1993","unstructured":"Altomare GF, Capella GL, Pigatto PD, Finzi AF (1993) Intramuscular low dose alpha-2B interferon and etretinate for treatment of mycosis fungoides. Int J Dermatol 32:138\u2013141","journal-title":"Int J Dermatol"},{"key":"27_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/0140-6736(90)93039-R","volume":"335","author":"J Atzpodien","year":"1990","unstructured":"Atzpodien J, K\u00f6rfer A, Franks CR, Poliwoda H, Kirchner H (1990) Home therapy with recombinant interleukin-2 and interferon-a-2b in advanced human malignancies. Lancet 335:1509\u20131512","journal-title":"Lancet"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00000421-199010000-00008","volume":"13","author":"E Bajetta","year":"1990","unstructured":"Bajetta E, Negretti E, Giannotti B et al (1990) Phase II study of interferon-alpha-2a and dacarbazine in advanced melanoma. Am J Clin Oncol 13:405\u2013409","journal-title":"Am J Clin Oncol"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/BF02115785","volume":"69","author":"R Baumann","year":"1991","unstructured":"Baumann R, Tauber MG, Opravil M, Hirschel B, Kinloch S, Chave JP, Pletscher M, Luthy R (1991) Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi\u2019s sarcoma. Klin Wochenschr 69: 360\u2013367","journal-title":"Klin Wochenschr"},{"key":"27_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/0140-6736(93)93174-Y","volume":"341","author":"P Boente","year":"1993","unstructured":"Boente P, Sampaio C, Brandao MA, Moreira ED, Badaro R, Jones TC (1993) Local perilesional therapy with rhGM-CSF for Kaposi\u2019s sarcoma (letter). Lancet 341:1154","journal-title":"Lancet"},{"key":"27_CR7","first-page":"1090","volume":"9","author":"S Breier","year":"1990","unstructured":"Breier S, Pensei R, Roffe C et al (1990) High dose DTIC with recombinant human interferon alpha-2b (rhifn2b) for the treatment of metastatic malignant melanoma (MMM). Proc Annu Meet Am Soc Clin Oncol 9:A1090","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/1523-1747.ep12722644","volume":"92","author":"NH Brockmeyer","year":"1989","unstructured":"Brockmeyer NH, Mertins L, Daecke C, Goos M (1989) Regression of Kaposi\u2019s sarcoma and improvement of performance status by a combined interferon beta and zidovudine therapy in AIDS patients. J Invest Dermatol 92:776","journal-title":"J Invest Dermatol"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","volume":"178","author":"MJ Brunda","year":"1993","unstructured":"Brunda MJ, Luistro L, Wright RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223\u20131230","journal-title":"J Exp Med"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1523-1747.ep12494210","volume":"98","author":"MM Brysk","year":"1992","unstructured":"Brysk MM, Santschi CH, Bell T, Wagner RF Jr, Tyring SK, Rajaraman S (1992) Culture of basal cell carcinoma. J Invest Dermatol 98:45\u201349","journal-title":"J Invest Dermatol"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0190-9622(91)70111-E","volume":"24","author":"SA Buechner","year":"1991","unstructured":"Buechner SA (1991) Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression. J Am Acad Dermatol 24:731\u2013734","journal-title":"J Am Acad Dermatol"},{"key":"27_CR12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-101-4-484","volume":"101","author":"PA Bunn Jr","year":"1984","unstructured":"Bunn PA Jr, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R (1984) Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 101: 484\u2013487","journal-title":"Ann Intern Med"},{"key":"27_CR13","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/1097-0142(19860415)57:8+<1689::AID-CNCR2820571311>3.0.CO;2-M","volume":"57","author":"PA Bunn Jr","year":"1986","unstructured":"Bunn PA Jr, Ihde DC, Foon KA (1986) The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer 57:1689\u20131695","journal-title":"Cancer"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00008390-199304000-00007","volume":"3","author":"G Castello","year":"1993","unstructured":"Castello G, Cornelia P, Manzo T, Napolitano M, Parziale AP, Galati MG, Daponte A, Casaretti R, Celentano E, Cornelia G (1993) Immunological and clinical effects of intramuscular rIFN alpha-2a and low dose subcutaneous rIL-2 in patients with advanced malignant melanoma. Melanoma Res 3:43\u201349","journal-title":"Melanoma Res"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/archderm.129.9.1136","volume":"129","author":"P Celerier","year":"1993","unstructured":"Celerier P, Fleischmann M, Basset Seguin N, Thill L, Bureau B, Litoux P, Dreno B (1993) In vitro induction of basal keratinocyte MY7 antigen expression in cutaneous T-cell lymphoma is associated with response to interferon-alfa therapy. Arch Dermatol 129:1136\u20131140","journal-title":"Arch Dermatol"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/0190-9622(90)70276-N","volume":"23","author":"RC Cornell","year":"1990","unstructured":"Cornell RC, Greenway HY, Tucker SB, Edwards L, Ashworth S, Vance JC, Tanner DJ, Taylor EL, Smiles KA, Peets EA (1990) Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 23:694\u2013700","journal-title":"J Am Acad Dermatol"},{"key":"27_CR17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/j.1098-2388.1993.tb00020.x","volume":"9","author":"NJ Crowley","year":"1993","unstructured":"Crowley NJ, Seigier HF (1993) Possibilities of immunotherapy and gene therapy for malignant melanoma. Semin Surg Oncol 9:273\u2013278","journal-title":"Semin Surg Oncol"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/infdis\/164.1.43","volume":"164","author":"RT Davey Jr","year":"1991","unstructured":"Davey RT Jr, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC (1991) A phase I\/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection. J Infect Dis 164: 43\u201352","journal-title":"J Infect Dis"},{"key":"27_CR19","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1200\/JCO.1991.9.10.1821","volume":"9","author":"PA Demchak","year":"1990","unstructured":"Demchak PA, Mier JW, Robert NJ et al (1990) Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study. J Clin Oncol 9:1821\u20131830","journal-title":"J Clin Oncol"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/jnci\/82.16.1345","volume":"82","author":"RO Dillman","year":"1990","unstructured":"Dillman RO, Oldham RK, Barth NM et al (1990) Recombinant interleukin-2 and adoptive immunotherapy alternated with dacarbazine therapy in melanoma: a National Biotherapy Study Group trial. J Natl Cancer Inst 82:1345\u20131349","journal-title":"J Natl Cancer Inst"},{"key":"27_CR21","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/1097-0142(19930401)71:7<2358::AID-CNCR2820710730>3.0.CO;2-M","volume":"71","author":"RO Dillman","year":"1993","unstructured":"Dillman RO, Church C, Oldham RK, West WH, Schwartzberg L, Birch R (1993) Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experience. Cancer 71:2358\u20132370","journal-title":"Cancer"},{"key":"27_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2133.1992.tb00672.x","volume":"126","author":"B Dreno","year":"1992","unstructured":"Dreno B, Fleischmann M, Valard S, Godefroy W, Bureau B, Stadler JF, Litoux P (1992) Induction of myelo-monocytic My7 antigen (CD13) expression by interferon-alpha in basal cells of cutaneous T-cell lymphomas. Br J Dermatol 126:320\u2013323","journal-title":"Br J Dermatol"},{"issue":"[Suppl l]","key":"27_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000204582","volume":"89","author":"B Dreno","year":"1993","unstructured":"Dreno B, Celerier P, Litoux P (1993) Roferon-A in combination with Tigason in cutaneous T-cell lymphomas. Acta Haematol 89 [Suppl l]:28\u201332","journal-title":"Acta Haematol"},{"key":"27_CR24","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/1097-0142(19910501)67:9<2300::AID-CNCR2820670916>3.0.CO;2-A","volume":"67","author":"R Dummer","year":"1991","unstructured":"Dummer R, Muller W, Nestle F, Wiede J, Dues J, Lechner W, Haubitz I, Wolf W, Bill E, Burg G (1991) Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-rish malignant melanoma patients. Cancer 67:2300\u20132304","journal-title":"Cancer"},{"key":"27_CR25","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/archderm.126.8.1029","volume":"126","author":"L Edwards","year":"1990","unstructured":"Edwards L, Tucker SB, Perednia D, Smiles KA, Taylor EL, Tanner DJ, Peets E (1990) The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas. Arch Dermatol 126:1029\u20131032","journal-title":"Arch Dermatol"},{"key":"27_CR26","first-page":"266","volume":"40","author":"U Els\u00e4sser Beile","year":"1989","unstructured":"Els\u00e4sser Beile U, Garbe C, Stadler R, Drews H, Sch\u00f6pf E (1989) Adjuvante Therapie mit rekombiniertem Interferon alfa-2a beim metastasierten malignen Melanom. Hautarzt 40:266\u2013270","journal-title":"Hautarzt"},{"key":"27_CR27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/JCO.1991.9.8.1403","volume":"9","author":"CI Falkson","year":"1991","unstructured":"Falkson CI, Falkson G, Falkson HC (1991) Improved results with the addition of recombinant interferon alpha-2b to dacarbazine in treatment of patients with metastatic malignant melanoma. J Clin Oncol 9:1403\u20131408","journal-title":"J Clin Oncol"},{"key":"27_CR28","first-page":"16","volume":"43","author":"G Fierlbeck","year":"1992","unstructured":"Fierlbeck G, d\u2019Hoedt B, Stroebel W, Stutte H, Bogensch\u00fctz O, Rassner G (1992) Intral\u00e4sionale Therapie von Melanommetastasen mit rekombinantem Interferonbeta. Hautarzt 43:16\u201321","journal-title":"Hautarzt"},{"key":"27_CR29","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1016\/0002-9343(91)90404-L","volume":"90","author":"MA Fischl","year":"1991","unstructured":"Fischl MA (1991) Antiretroviral therapy in combination with interferon for AIDS-related Kaposi\u2019s sarcoma. Am J Med 90:2S\u20137S","journal-title":"Am J Med"},{"issue":"[Suppl 1]","key":"27_CR30","first-page":"4","volume":"6","author":"M Fischl","year":"1986","unstructured":"Fischl M, Lucas S, Gorowski E et al (1986) Interferon alpha-N1 Wellferon (WFN) in Kaposi\u2019s sarcoma: single agent or combination with vinblastine (VBL). J Interferon Res 6 [Suppl 1]:4 (abstr)","journal-title":"J Interferon Res"},{"key":"27_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-199101000-00001","volume":"4","author":"MA Fischl","year":"1991","unstructured":"Fischl MA, Uttamchandani RB, Resnick L, Agarwal R, Fletcher MA, Patrone Reese J, Dearmas L, Chidekel J, McCann M, Myers M (1991) A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi\u2019s sarcoma. J Acquir Immune Defic Syndr 4:1\u201310","journal-title":"J Acquir Immune Defic Syndr"},{"key":"27_CR32","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/1097-0142(19900601)65:11<2471::AID-CNCR2820651113>3.0.CO;2-F","volume":"65","author":"LE Flaherty","year":"1990","unstructured":"Flaherty LE, Redman BG, Chabot GG et al (1990) A phase I\u2013II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma. Cancer 65:2471\u20132477","journal-title":"Cancer"},{"issue":"[3 Suppl]","key":"27_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/1097-0142(19870201)59:3+<601::AID-CNCR2820591304>3.0.CO;2-J","volume":"59","author":"KA Foon","year":"1987","unstructured":"Foon KA, Roth MS, Bunn PA Jr (1987) Interferon therapy of non-Hodgkin\u2019s lymphoma. Cancer 59 [3 Suppl]:601\u2013604","journal-title":"Cancer"},{"key":"27_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000215998","volume":"9","author":"A Ganser","year":"1986","unstructured":"Ganser A, Brucher W, Brodt HR, Busch W, Brandhorst I, Helm EB, Hoelzer D (1986) Treatment of AIDS-related Kaposi\u2019s sarcoma with recombinant gamma-interferon. Onkologie 9:163\u2013166","journal-title":"Onkologie"},{"key":"27_CR35","doi-asserted-by":"publisher","first-page":"239S","DOI":"10.1038\/jid.1993.42","volume":"100","author":"C Garbe","year":"1993","unstructured":"Garbe C, Krasagakis K (1993) Effects of interferons and cytokines on melanoma cells. J Invest Dermatol 100:239S\u2013244S","journal-title":"J Invest Dermatol"},{"key":"27_CR36","doi-asserted-by":"publisher","first-page":"231S","DOI":"10.1111\/1523-1747.ep12875837","volume":"95","author":"C Garbe","year":"1990","unstructured":"Garbe C, Krasagakis K, Zouboulis C, Schr\u00f6der K, Kr\u00fcger S, Stadler R, Orfanos CE (1990) Antitumor activities of interferon-alpha, -beta and -gamma on malignant melanoma cells in vitro. Changes of proliferation, melanin synthesis and immuno-phenotype. J Invest Dermatol 95:231S\u2013237S","journal-title":"J Invest Dermatol"},{"issue":"[Suppl 4]","key":"27_CR37","first-page":"63","volume":"19","author":"C Garbe","year":"1992","unstructured":"Garbe C, Kreuser ED, Zouboulis CC, Stadler R, Orfanos CE (1992) Combined treatment of metastatic melanoma with interferons and cytotoxic drugs. Semin Oncol 19 [Suppl 4]:63\u201369","journal-title":"Semin Oncol"},{"key":"27_CR38","unstructured":"Garbe C, Zouboulis ChC, Stadler R et al (1994) Prolongation of life in stage IV melanoma by combined treatment with IFN-a-2a and vindesine (submitted for publication)"},{"key":"27_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0002-9343(85)90276-1","volume":"78","author":"EP Gelmann","year":"1985","unstructured":"Gelmann EP, Preble OT, Steis R, Lane HC, Rook AH, Wesley M, Jacob J, Fauci A, Masur H, Longo D (1985) Human lymphoblastoid interferon treatment of Kaposi\u2019s sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. Am J Med 78:737\u2013741","journal-title":"Am J Med"},{"key":"27_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0190-9622(86)70192-8","volume":"15","author":"HT Greenway","year":"1986","unstructured":"Greenway HT, Cornell RC, Tanner DJ, Peets E, Bordin GM, Nagi C (1986) Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 15:437\u2013443","journal-title":"J Am Acad Dermatol"},{"key":"27_CR41","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(88)91620-0","volume":"1","author":"JJ Grob","year":"1988","unstructured":"Grob JJ, Collet AM, Munoz MH, Bonerandi JJ (1988) Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a. Lancet 1:878\u2013879","journal-title":"Lancet"},{"key":"27_CR42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-100-5-671","volume":"100","author":"JE Groopman","year":"1984","unstructured":"Groopman JE, Gottlieb MS, Goodman J, Mitsuyasu RT, Conant MA, Prince H, Fahey JL, Derezin M, Weinstein WM, Casavante C et al (1984) Recombinant alpha-2 interferon herapy for Kaposi\u2019s sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 100:671\u2013676","journal-title":"Ann Intern Med"},{"key":"27_CR43","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/1097-0142(19891015)64:8<1617::AID-CNCR2820640811>3.0.CO;2-Q","volume":"64","author":"S Gundersen","year":"1989","unstructured":"Gundersen S, Flokkmann A (1989) Interferon in combination with vinblastine in advanced malignant melanoma. A phase I\u2013II study. Cancer 64:1617\u20131619","journal-title":"Cancer"},{"key":"27_CR44","first-page":"A1029","volume":"10","author":"TJ Hamblin","year":"1991","unstructured":"Hamblin TJ, Davies B, Sadullah S, Oskam R, Palmer P, Franks CR (1991) A phase II study of the treatment of metastatic malignant melanoma with a combination of dacarbazine, cisplatin, interleukin-2 (IL-2) and alfa-interferon (IFN). Proc Annu Meet Am Soc Clin Oncol 10:A1029","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR45","first-page":"789","volume":"43","author":"A Hauschild","year":"1992","unstructured":"Hauschild A, Petres Dunsche C (1992) Intral\u00e4sion\u00e4re Behandlung des klassischen Kaposi-Sarkoms mit Interferon alpha. Hautarzt 43:789\u2013791","journal-title":"Hautarzt"},{"key":"27_CR46","first-page":"584","volume":"3","author":"W Heagy","year":"1990","unstructured":"Heagy W, Groopman J, Schindler J, Finberg R (1990) Use of IFN-gamma in patients with AIDS. J Acquir Immune Defic Syndr 3:584\u2013590","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"[Suppl 2]","key":"27_CR47","first-page":"118","volume":"9","author":"P Hersey","year":"1989","unstructured":"Hersey P, McLeod RC, Thomson DB (1989) Phase I\/II study of tolerability and efficacy of recombinant interferon (Roferon) with dacarbazine (DTIC) in advanced malignant melanoma. J Interferon Res 9 [Suppl 2]: 118","journal-title":"J Interferon Res"},{"key":"27_CR48","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/bjs.1800791005","volume":"79","author":"AD Hill","year":"1992","unstructured":"Hill AD, Redmond HP, Croke DT, Grace PA, Bouchier Hayes D (1992) Cytokines in tumour therapy. Br J Surg 79:990\u2013997","journal-title":"Br J Surg"},{"key":"27_CR49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/84.15.1185","volume":"84","author":"TG Johns","year":"1992","unstructured":"Johns TG, Mackay IR, Callister KA, Hertzog PJ, Devenish RJ, Linnane AW (1992) Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. J Natl Cancer Inst 84:1185\u20131190","journal-title":"J Natl Cancer Inst"},{"key":"27_CR50","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/1097-0142(19930715)72:2<607::AID-CNCR2820720245>3.0.CO;2-R","volume":"72","author":"U Keilholz","year":"1993","unstructured":"Keilholz U, Scheibenbogen C, Tilgen W, Bergmann L, Weidmann E, Seither E, Richter M, Brado B, Mitrou PS, Hunstein W (1993) Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials. Cancer 72:607\u2013614","journal-title":"Cancer"},{"key":"27_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00204991","volume":"28","author":"P Kellokumpu-Lehtinen","year":"1989","unstructured":"Kellokumpu-Lehtinen P, Nordman E, Toivanen A (1989) Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of treatment on immunological functions. Cancer Immunol Immunother 28:213\u2013217","journal-title":"Cancer Immunol Immunother"},{"key":"27_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000216368","volume":"10","author":"P Kern","year":"1987","unstructured":"Kern P, Meigel W, Racz P, Gottesleben A, Dettke T, Dietrich M (1987) Interferon alpha in the treatment of AIDS-associated Kaposi\u2019s sarcoma. Onkologie 10:50\u201352","journal-title":"Onkologie"},{"key":"27_CR53","first-page":"A1122","volume":"8","author":"R Kerr","year":"1989","unstructured":"Kerr R, Pippen P, Mennel R, Jones S (1989) Treatment of metastatic malignant melanoma with a combination of interferon-alpha-2a (IFN-alpha-2a, Roferon) and dacarbazine (DTIC). Proc Annu Meet Am Soc Clin Oncol 8:A1122","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1990.8.1.155","volume":"8","author":"EC Kohn","year":"1990","unstructured":"Kohn EC, Steis RG, Sausville EA, Veach SR, Stocker JL, Phelps R, Franco S, Longo DL, Bunn PA, Ihde DC (1990) Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sezary syndrome. J Clin Oncol 8:155\u2013160","journal-title":"J Clin Oncol"},{"key":"27_CR55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-111-4-280","volume":"111","author":"JA Kovacs","year":"1989","unstructured":"Kovacs JA, Deyton L, Davey R, Falloon J, Zunich K, Lee D, Metcalf JA, Bigley JW, Sawyer LA, Zoon KC et al (1989) Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 111:280\u2013287","journal-title":"Ann Intern Med"},{"key":"27_CR56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/1523-1747.ep12480767","volume":"97","author":"K Krasagakis","year":"1991","unstructured":"Krasagakis K, Garbe C, Kruger S, Orfanos CE (1991) Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol 97:364\u2013372","journal-title":"J Invest Dermatol"},{"key":"27_CR57","first-page":"358","volume":"4","author":"RL Krigel","year":"1985","unstructured":"Krigel RL, Odajnyk CM, Laubenstein LJ, Ostreicher R, Wernz J, Vilcek J, Pubinstein P, Friedman Kien AE (1985) Therapeutic trial of interferon-gamma in patients with epidemic Kaposi\u2019s sarcoma. J Biol Response Mod 4:358\u2013364","journal-title":"J Biol Response Mod"},{"key":"27_CR58","first-page":"359","volume":"8","author":"RL Krigel","year":"1989","unstructured":"Krigel RL, Padavic Shaller KA, Rudolph AR, Poiesz BJ, Comis RL (1989) Exacerbation of epidemic Kaposi\u2019s sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study. J Biol Response Mod 8:359\u2013365","journal-title":"J Biol Response Mod"},{"key":"27_CR59","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJM198305053081806","volume":"308","author":"SE Krown","year":"1983","unstructured":"Krown SE, Real FX, Cunningham Rundles S, Myskowski PL, Koziner B, Fein S, Mittelman A, Oettgen HF, Safai B (1983) Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi\u2019s sarcoma. N Engl J Med 308:1071\u20131076","journal-title":"N Engl J Med"},{"issue":"[8 Suppl]","key":"27_CR60","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/1097-0142(19860415)57:8+<1662::AID-CNCR2820571305>3.0.CO;2-Y","volume":"57","author":"SE Krown","year":"1986","unstructured":"Krown SE, Real FX, Vadhan Raj S, Cunningham Rundles S, Krim M, Wong G, Oettgen HF (1986) Kaposi\u2019s sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors. Cancer 57 [8 Suppl]: 1662\u20131665","journal-title":"Cancer"},{"key":"27_CR61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/0003-4819-112-11-812","volume":"112","author":"SE Krown","year":"1990","unstructured":"Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ (1990) Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologie effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:812\u2013821","journal-title":"Ann Intern Med"},{"key":"27_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/jnci\/82.3.203","volume":"82","author":"TM Kuzel","year":"1990","unstructured":"Kuzel TM, Gilyon K, Springer E, Variakojis D, Kaul K, Bunn PA Jr, Evans L, Roenigk HH Jr, Rosen ST (1990) Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82:203\u2013207","journal-title":"J Natl Cancer Inst"},{"key":"27_CR63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jnci\/84.2.119","volume":"84","author":"TM Kuzel","year":"1992","unstructured":"Kuzel TM, Roenigk HH Jr, Samuelson E, Rosen ST (1992) Suppression of anti-interferon alpha-2a antibody formation in patients with mycosis fungoides by exposure to long-wave UV radiation in the A range and methoxsalen ingestion. J Natl Cancer Inst 84:119\u2013121","journal-title":"J Natl Cancer Inst"},{"key":"27_CR64","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0190-9622(89)80151-3","volume":"20","author":"M Landthaler","year":"1989","unstructured":"Landthaler M, Braun Falco O (1989) Adjuvant therapy of high-risk malignant melanoma patients with gamma interferon. J Am Acad Dermatol 20:687\u2013688","journal-title":"J Am Acad Dermatol"},{"key":"27_CR65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF00918667","volume":"9","author":"HC Lane","year":"1989","unstructured":"Lane HC, Davey RT Jr, Sherwin SA, Masur H, Rook AH, Manischewitz JF, Quinnan GV, Smith PD, Easter ME, Fauci AS (1989) A phase I trial of recombinant human interferon-gamma in patients with Kaposi\u2019s sarcoma and the acquired immunodeficiency syndrome (AIDS). J Clin Immunol 9:351\u2013361","journal-title":"J Clin Immunol"},{"key":"27_CR66","first-page":"A1179","volume":"11","author":"S Legha","year":"1992","unstructured":"Legha S, Plager C, Ring S, Eton O, Talpaz J, Gutterman J, Benjamin RS (1992) A phase II study of biochemotherapy using interleukin-2 (IL-2) + Interferon alfa-2a (IFN) in combination with cisplatin (C) vinblastine (V) and DTIC (D) in patients with metastatic melanoma. Proc Annu Meet Am Soc Clin Oncol 11:A1179","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF00117794","volume":"8","author":"PL Lollini","year":"1990","unstructured":"Lollini PL, De Giovanni C, Nicoletti G, Bontadini A, Tazzari PL, Landuzzi L, Scotlandi K, Nanni P (1990) Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma. Clin Exp Metastasis 8:215\u2013224","journal-title":"Clin Exp Metastasis"},{"key":"27_CR68","doi-asserted-by":"publisher","first-page":"18S","DOI":"10.1111\/1523-1747.ep12281128","volume":"83","author":"MA Lutzner","year":"1984","unstructured":"Lutzner MA, Blanchet Bardon C, Orth G (1984) Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 83: 18S-25S","journal-title":"J Invest Dermatol"},{"key":"27_CR69","first-page":"A1074","volume":"9","author":"K Margolin","year":"1990","unstructured":"Margolin K, Doroshow J, Akman S et al (1990) Treatment (RX) of advanced melanoma with cis-diamminedichloroplatinum (CDDP) and alpha interferon (alpha IFN). Proc Annu Meet Am Soc Clin Oncol 9:A1074","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR70","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/jnci\/82.12.1071-a","volume":"82","author":"FL Meyskens Jr","year":"1990","unstructured":"Meyskens FL Jr, Kopecky K, Samson M, Hersh E, Macdonald J, Jaffe H, Crowley J, Coliman C (1990) Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma. J Natl Cancer Inst 82:1071","journal-title":"J Natl Cancer Inst"},{"key":"27_CR71","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-112-8-582","volume":"112","author":"SA Miles","year":"1990","unstructured":"Miles SA, Wang HJ, Cortes E, Carden J, Marcus S, Mitsuyasu RT (1990) Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections. Ann Intern Med 112:582\u2013589","journal-title":"Ann Intern Med"},{"key":"27_CR72","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/archderm.129.6.747","volume":"129","author":"EN Mostow","year":"1993","unstructured":"Mostow EN, Neckel SL, Oberhelman L, Anderson TF, Cooper KD (1993) Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Arch Dermatol 129:747\u2013752","journal-title":"Arch Dermatol"},{"key":"27_CR73","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF00375725","volume":"282","author":"N Mozzanica","year":"1990","unstructured":"Mozzanica N, Cattaneo A, Boneschi V, Brambilla L, Melotti E, Finzi AF (1990) Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon. Arch Dermatol Res 282:311\u2013317","journal-title":"Arch Dermatol Res"},{"key":"27_CR74","first-page":"A1083","volume":"9","author":"NH Mulder","year":"1990","unstructured":"Mulder NH, Schraffordt-Koops H, Sleijfer DT et al (1990) Dacarbazine and alpha-interferon for disseminated malignant melanoma. Proc Annu Meet Am Soc Clin Oncol 9:A1083","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR75","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000248098","volume":"179","author":"JF Nicolas","year":"1989","unstructured":"Nicolas JF, Balblanc JC, Frappaz A, Chouvet B, Delcombel M, Thivolet J (1989) Treatment of cutaneous T cell lymphoma with intermediate doses of interferon alpha 2a. Dermatologica 179:34\u201337","journal-title":"Dermatologica"},{"key":"27_CR76","first-page":"3561","volume":"53","author":"M Ogasawara","year":"1993","unstructured":"Ogasawara M, Rosenberg SA (1993) Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes. Cancer Res 53: 3561\u20133568","journal-title":"Cancer Res"},{"key":"27_CR77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0190-9622(89)70049-9","volume":"20","author":"EA Olsen","year":"1989","unstructured":"Olsen EA, Rosen ST, Vollmer RT, Variakojis D, Roenigk HH Jr, Diab N, Zeffren J (1989) Interferon alfa-2a in the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol 20:395\u2013407","journal-title":"J Am Acad Dermatol"},{"key":"27_CR78","first-page":"A1123","volume":"8","author":"R Oratz","year":"1989","unstructured":"Oratz R, Dugan M, Walsh C et al (1989) Phase II trial of r-alpha 2b-interferon (IFN) and cisplatin (CDDP) in metastatic malignant melanoma (MM). Proc Annu Meet Am Soc Clin Oncol 8:A1123","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR79","first-page":"695","volume":"43","author":"HG Otte","year":"1992","unstructured":"Otte HG, Herges A, Stadler R (1992) Kombinationstherapie mit Interferon alfa 2a und PUVA bei kutanen T-Zell-Lymphomen. Hautarzt 43:695\u2013699","journal-title":"Hautarzt"},{"key":"27_CR80","first-page":"647","volume":"85","author":"A Plettenberg","year":"1990","unstructured":"Plettenberg A, Kern P, Dietrich M, Meigel W (1990) Rekombinantes Interferon alpha 2A in der Behandlung des HIV-assoziierten Kaposi-Sarkoms. Langzeitergebnisse. Med Klin 85:647\u2013652","journal-title":"Med Klin"},{"key":"27_CR81","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1200\/JCO.1992.10.12.1919","volume":"10","author":"S Pyrhonen","year":"1992","unstructured":"Pyrhonen S, Hahka Kemppinen M, Muhonen T (1992a) A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. J Clin Oncol 10: 1919\u20131926","journal-title":"J Clin Oncol"},{"key":"27_CR82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000227004","volume":"49","author":"S Pyrhonen","year":"1992","unstructured":"Pyrhonen S, Kouri M, Holsti LR, Cantell K (1992b) Disease stabilization by leukocyte alpha interferon and survival of patients with metastatic melanoma. Oncology 49:22\u201326","journal-title":"Oncology"},{"key":"27_CR83","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/JCO.1986.4.4.544","volume":"4","author":"FX Real","year":"1986","unstructured":"Real FX, Oettgen HF, Krown SE (1986) Kaposi\u2019s sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 4:544\u2013551","journal-title":"J Clin Oncol"},{"key":"27_CR84","first-page":"A1189","volume":"11","author":"J Richards","year":"1992","unstructured":"Richards J, Mehta N, Schroeder L, Dordal A (1992a) Sequential chemotherapy\/immunotherapy for metastatic melanoma. Proc Annu Meet Am Soc Clin Oncol 11:A1189","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR85","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.1992.10.8.1338","volume":"10","author":"JM Richards","year":"1992","unstructured":"Richards JM, Mehta N, Ramming K, Skosey P (1992b) Sequential chemoimmuno-therapy in the treatment of metastatic melanoma. J Clin Oncol 10:1338\u20131343","journal-title":"J Clin Oncol"},{"key":"27_CR86","first-page":"A1085","volume":"9","author":"J Richner","year":"1990","unstructured":"Richner J, Cerny T, Joss RA et al (1990) A phase II study of continuous sc alpha-2b interferon (IFN) combined with cisplatin (CDDP) in advanced malignant melanoma (MM). Proc Annu Meet Am Soc Clin Oncol 9:A1085","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR87","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.1985.3.4.506","volume":"3","author":"A Rios","year":"1985","unstructured":"Rios A, Mansell PW, Newell GR, Reuben JM, Hersh EM, Gutterman JU (1985) Treatment of acquired immunodeficiency syndrome-related Kaposi\u2019s sarcoma with lymphoblastoid interferon. J Clin Oncol 3:506\u2013512","journal-title":"J Clin Oncol"},{"issue":"6","key":"27_CR88","doi-asserted-by":"publisher","first-page":"198S","DOI":"10.1111\/1523-1747.ep12875523","volume":"95","author":"HH Roenigk Jr","year":"1990","unstructured":"Roenigk HH Jr, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Variakojis D, Kaul K, Bunn PA Jr et al (1990) Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95 [Suppl 6]:198S\u2013205S","journal-title":"J Invest Dermatol"},{"key":"27_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF01516943","volume":"37","author":"IG Ron","year":"1993","unstructured":"Ron IG, Inbar MJ, Gutman M, Merimsky O, Chaitchik S (1993) Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients. Cancer Immunol Immunother 37:61\u201366","journal-title":"Cancer Immunol Immunother"},{"key":"27_CR90","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","volume":"313","author":"SA Rosenberg","year":"1985","unstructured":"Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485\u20131492","journal-title":"N Engl J Med"},{"key":"27_CR91","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1001\/jama.268.17.2416","volume":"268","author":"SA Rosenberg","year":"1992","unstructured":"Rosenberg SA (1992) Gene therapy for cancer. JAMA 268:2416\u20132419","journal-title":"JAMA"},{"key":"27_CR92","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/00000658-198910000-00008","volume":"210","author":"SA Rosenberg","year":"1989","unstructured":"Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE (1989a) Experience with the use of high dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 210:474\u2013485","journal-title":"Ann Surg"},{"key":"27_CR93","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1200\/JCO.1989.7.12.1863","volume":"7","author":"SA Rosenberg","year":"1989","unstructured":"Rosenberg SA, Lotze MT, Yang JC, Linehan WM, Seipp C, Calabro S, Karp SE, Sherry RM, Steinberg S, White DE (1989b) Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. J Clin Oncol 7:1863\u20131874","journal-title":"J Clin Oncol"},{"key":"27_CR94","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0609.1993.tb01595.x","volume":"51","author":"C Ross","year":"1993","unstructured":"Ross C, Tingsgaard P, Jorgensen H, Vejlsgaard GL (1993) Interferon treatment of cutaneous T-cell lymphoma. Eur J Haematol 51:63\u201372","journal-title":"Eur J Haematol"},{"issue":"6","key":"27_CR95","doi-asserted-by":"publisher","first-page":"161S","DOI":"10.1111\/1523-1747.ep12875174","volume":"95","author":"W Rozenbaum","year":"1990","unstructured":"Rozenbaum W, Gharakhanian S, Navarette MS, De Sahb R, Cardon B, Rouzioux C (1990) Long-term follow-up of 120 patients with AIDS-related Kaposi\u2019s sarcoma treated with interferon alpha-2a. J Invest Dermatol 95 [Suppl 6]:161S\u2013165S","journal-title":"J Invest Dermatol"},{"key":"27_CR96","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/1043-4666(90)90024-N","volume":"2","author":"LA Sawyer","year":"1990","unstructured":"Sawyer LA, Metcalf JA, Zoon KC, Boone EJ, Kovacs JA, Lane HC, Quinnan GV Jr (1990) Effects of interferon-alpha in patients with AIDS-associated Kaposi\u2019s sarcoma are related to blood interferon levels and dosse. Cytokine 2:247\u2013252","journal-title":"Cytokine"},{"issue":"[Suppl l]","key":"27_CR97","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/00000421-199112001-00008","volume":"14","author":"DT Scadden","year":"1991","unstructured":"Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE (1991a) GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi\u2019s sarcoma. Am J Clin Oncol 14 [Suppl l]:S40\u201344","journal-title":"Am J Clin Oncol"},{"key":"27_CR98","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1200\/JCO.1991.9.5.802","volume":"9","author":"DT Scadden","year":"1991","unstructured":"Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE (1991b) Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi\u2019s sarcoma. J Clin Oncol 9:802\u2013808","journal-title":"J Clin Oncol"},{"key":"27_CR99","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2133.1991.tb03283.x","volume":"124","author":"FM Schaart","year":"1991","unstructured":"Schaart FM, Bratzke B, Ruszczak Z, Stadler R, Ehlers G, Orfanos CE (1991) Long-term therapy of HIV-associated Kaposi\u2019s sarcoma with recombinant interferon alpha-2a. Br J Dermatol 124:62\u201368","journal-title":"Br J Dermatol"},{"key":"27_CR100","first-page":"700","volume":"43","author":"K Schr\u00f6der","year":"1992","unstructured":"Schr\u00f6der K, Garbe C, Waibel M, Reupke H, Detmar M, Dallenbach F, Orfanos CE (1992) Granulozyten-Koloniestimulierender Faktor (G-CSF) in der Behandlung von Patienten mit HIV-assoziiertem mukokutanem Kaposi-Sarkom. Erfolgreicher Einsatz bei virus- bzw. medikamenteninduzierter Leukopenie. Hautarzt 43: 700\u2013706","journal-title":"Hautarzt"},{"key":"27_CR101","first-page":"A1120","volume":"8","author":"L Schuchter","year":"1989","unstructured":"Schuchter L, McGuire WP, Wohlganger J, Redden T (1989) Sequential treatment of metastatic melanoma with interferon-alpha (IFN) plus cis-platinum (CDDP). Proc Annu Meet Am Soc Clin Oncol 8:A1120","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR102","first-page":"A1185","volume":"11","author":"MR Sertoli","year":"1992","unstructured":"Sertoli MR, Queirolo P, Bajetta E et al (1992) Dacarbazine (DTIC) with or without recombinant interferon alpha-2a at different dosages in the treatment of stage IV melanoma patients. Preliminary results of a randomized trial. Proc Annu Meet Am Soc Clin Oncol 11:A1185","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR103","first-page":"93","volume":"1","author":"R Simoni","year":"1987","unstructured":"Simoni R, Cavalieri R, Coppola G, Ricciotti L, De Pita O, Criscuolo D, Covelli A, Papa G, Mandelli F (1987) Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides. J Biol Regul Homeost Agents 1:93\u201399","journal-title":"J Biol Regul Homeost Agents"},{"key":"27_CR104","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0959-8049(05)80071-1","volume":"28","author":"KA Smith","year":"1992","unstructured":"Smith KA, Green JA, Eccles JM (1992) Interferon alpha 2a and vindesine in the treatment of advanced malignant melanoma. Eur J Cancer 28:438\u2013441","journal-title":"Eur J Cancer"},{"key":"27_CR105","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/0190-9622(93)70149-N","volume":"29","author":"EA Springer","year":"1993","unstructured":"Springer EA, Kuzel TM, Variakojis D, Kaul K, Rosen ST, Roenigk HH Jr (1993) Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a. J Am Acad Dermatol 29:42\u201346","journal-title":"J Am Acad Dermatol"},{"key":"27_CR106","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-4362.1991.tb04627.x","volume":"30","author":"R Stadler","year":"1991","unstructured":"Stadler R, Garbe C (1991) Disseminated malignant melanoma. New therapeutic approaches. Int J Dermatol 30:239\u2013242","journal-title":"Int J Dermatol"},{"issue":"6","key":"27_CR107","doi-asserted-by":"publisher","first-page":"170S","DOI":"10.1111\/1523-1747.ep12875494","volume":"95","author":"R Stadler","year":"1990","unstructured":"Stadler R, Bratzke B, Schaart F, Orfanos CE (1990) Long-term combined rIFN-alpha-2a and zidovudine therapy for HIV-associated Kaposi\u2019s sarcoma: clinical consequences and side effects. J Invest Dermatol 95 [Suppl 6]:170S\u2013175S","journal-title":"J Invest Dermatol"},{"key":"27_CR108","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0190-9622(89)70246-2","volume":"21","author":"B Tank","year":"1989","unstructured":"Tank B, Habets JM, Naafs B, Damsma O, Stolz E, van Joost T (1989) Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma. J Am Acad Dermatol 21:734\u2013735","journal-title":"J Am Acad Dermatol"},{"key":"27_CR109","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-2133.1988.tb02600.x","volume":"118","author":"K Thestrup Pedersen","year":"1988","unstructured":"Thestrup Pedersen K, Hammer R, Kaltoft K, Sogaard H, Zachariae H (1988) Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate. Br J Dermatol 118:811\u2013818","journal-title":"Br J Dermatol"},{"key":"27_CR110","first-page":"A1177","volume":"11","author":"D Thomson","year":"1992","unstructured":"Thomson D, Adena M, McLeod GRC et al (1992) Interferon-2a (IFN) does not improve response or survival when added to dacarbazine (DTIC) in metastatic melanoma: results of a multi-institutional Australian randomized trial QMP8704. Proc Annu Meet Am Soc Clin Oncol 11:A1177","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"27_CR111","first-page":"337","volume":"72","author":"S Tura","year":"1987","unstructured":"Tura S, Mazza P, Zinzani PL, Ghetti PL, Poletti G, Gherlinzoni F, Montagnani A, Criscuolo D (1987) Alpha recombinant interferon in the treatment of mycosis fungoides (MF). Haematologica 72:337\u2013340","journal-title":"Haematologica"},{"key":"27_CR112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0609.1990.tb00903.x","volume":"52","author":"ML Vegna","year":"1990","unstructured":"Vegna ML, Papa G, Defazio D, Pisani F, Coppola G, De Pita O, Puddu P, Ferranti G, Simoni R, Mandelli F (1990) Interferon alpha-2a in cutaneous T-cell lymphoma. Eur J Haematol Suppl 52:32\u201335","journal-title":"Eur J Haematol Suppl"},{"key":"27_CR113","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1749-6632.1984.tb37165.x","volume":"437","author":"P Volberding","year":"1984","unstructured":"Volberding P, Valero R, Rothman J, Gee G (1984) Alpha interferon therapy of Kaposi\u2019s sarcoma in AIDS. Ann NY Acad Svi 437:439\u2013446","journal-title":"Ann NY Acad Svi"},{"issue":"3","key":"27_CR114","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/1097-0142(19870201)59:3+<620::AID-CNCR2820591309>3.0.CO;2-5","volume":"59","author":"PA Volberding","year":"1987","unstructured":"Volberding PA, Mitsuyasu RT, Golando JP, Spiegel RJ (1987) Treatment of Kaposi\u2019s sarcoma with interferon alfa-2b (Intron A). Cancer 59 [Suppl 3]:620\u2013625","journal-title":"Cancer"},{"key":"27_CR115","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/1097-0142(19880315)61:6<1071::AID-CNCR2820610603>3.0.CO;2-T","volume":"61","author":"P Wussow Von","year":"1988","unstructured":"Von Wussow P, Block B, Hartmann F, Deicher H (1988) Intralesional interferon-alpha therapy in advanced malignant melanoma. Cancer 61:1071\u20131074","journal-title":"Cancer"},{"issue":"4","key":"27_CR116","first-page":"949","volume":"70","author":"S Wadler","year":"1992","unstructured":"Wadler S (1992) The role of interferons in the treatment of solid tumors. Cancer 70 [Suppl 4]:949\u2013958","journal-title":"Cancer"},{"key":"27_CR117","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00002371-199302000-00006","volume":"13","author":"RP Whitehead","year":"1993","unstructured":"Whitehead RP, Figlin R, Citron ML, Pfile J, Moldawer N, Patel D, Jones G, Levitt D, Zeffren J (1993) A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma. J Immuno-ther 13:117\u2013121","journal-title":"J Immuno-ther"},{"key":"27_CR118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0190-9622(89)70009-8","volume":"20","author":"L Wickramasinghe","year":"1989","unstructured":"Wickramasinghe L, Hindson TC, Wacks H (1989) Treatment of neoplastic skin lesions with intralesional interferon. J Am Acad Dermatol 20:71\u201374","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"27_CR119","doi-asserted-by":"publisher","first-page":"206S","DOI":"10.1111\/1523-1747.ep12875616","volume":"95","author":"H Zachariae","year":"1990","unstructured":"Zachariae H, Thestrup Pedersen K (1990) Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95 [Suppl 6]:206S\u2013208S","journal-title":"J Invest Dermatol"}],"container-title":["Recent Results in Cancer Research","Skin Cancer: Basic Science, Clinical Research and Treatment"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-78771-3_27.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T22:14:38Z","timestamp":1713132878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-78771-3_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9783642787737","9783642787713"],"references-count":119,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-78771-3_27","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1995]]}}}